This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

5 Momentum Stocks to Watch: Isis, Rite Aid, Cavium, More

Stocks in this article: CAVM HZNP ISIS MACK RAD

NEW YORK (TheStreet) -- With the stock market showing strong technicals, here are five stocks to watch for continued upside momentum.

1. Cavium (CAVM) popped $2.90, or 6.24%, to $49.38 on 1.9 million shares on Tuesday. It took out a double top as it gapped above that and closed near the upper end of the range.

While it may be getting to the top of the channel, it may also be forming a mini-channel with a steeper ascent. If that happens, then it may reach up to the mid-$50's.

2. Horizon Pharma (HZNP) broke out of a wedge on Tuesday, popping 83 cents, or 6.17%, to $14.29 on 2.9 million shares. The stock has had a big run-up since August, with a pullback last month that broke the channel. It then formed a coil and held up pretty well.

The stock needs a follow-through to Tuesday's pop. A move above $15.15 could position the stock to test the highs at around $18.

3. Isis Pharmaceuticals (ISIS) is an example of a turn-around, particularly notable in some of the biotech stocks. On Tuesday, it was up $2.56, or 9.2%, to $30.37 on 5.2 million shares. The declining tops line was pierced on a breakaway gap. The moving averages have started to flatten out and curl up, and the stock may very well see a test of the 50-day at $33.68, which is the next target.

4. Merrimack Pharmaceuticals (MACK), after the pop and breakaway gap a few weeks ago, the stock coiled very tightly and quietly, and suddenly picked up. It's been up four days in a row, and on Tuesday it gained 48 cents, or 6.38%, to $8.00 on 2.6 million shares, taking out the May 1 $7.65 high.

I'm looking for $10.50 to $11 on this stock.

5. Rite Aid (RAD) followed through on Tuesday after breaking out last week, up 15 cents, or 1.85%, to $8.27 on 23 million shares. It looks like it's going to see $8.75 next.

See Harry's video chart analysis on these stocks.

>>Read More: Equity Pullback in the Cards but Outlook Will Brighten Later This Year

>>Read More: Workday Surges: What Wall Street's Saying

>>Read More: Helping Apple Haters Understand Why Android Is Doomed

>>Read More: How the iPad Can Get Even Bigger

At the time of publication, the author held no positions in any of the stocks mentioned.

This article represents the opinion of a contributor and not necessarily that of TheStreet or its editorial staff.

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs